Skip to main content
. 2022 Sep 23;2022:9688040. doi: 10.1155/2022/9688040

Figure 4.

Figure 4

External validation of the prognostic signature and nomogram for LUSC. (a) Comparison of OS between the high-risk and low-risk score groups in the validation cohort. (b) Time-dependent receiver operating characteristic analysis for evaluating the accuracy of the prognostic signature in the validation cohort. Calibration curve of the (c) 3- and (d) 5-year OS for the nomogram in the validation dataset. LUSC, lung squamous cell carcinoma; OS, overall survival (days).